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patient after preimpantation genetic diagnosis (PGD) treatment. DNA sequencing analysis conﬁrmed that the
hESC line carried the heterozygous deletion mutation, c.3536delA, of FBN1 gene. Characteristic tests proved
that the hESC line presented typicalmarkers of pluripotency and had the capability to form the three germ layers
both in vitro and in vivo.
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Human embryonic stem cell (hESC) line chHES-419 was derived
from abnormal blastocyst donated by Marfan syndrome patient who
underwent preimplantation genetic diagnosis (PGD) treatment. DNA
sequencing analysis conﬁrmed a heterozygous deletion mutation,d Stem Cell Engineering, School
ha, China.
icle under the CC BY-NC-ND licensec.3536delA, of FBN1 in the cells. The deletion caused a frameshift at
amino acid 1179 (glutamine) resulting in early termination after 25 ab-
normal amino acid residues (Q1179Rfs*25), indicating the pathogenic
effect of this mutation (Fig. 1A). The result is consistent with the
proband. The cells displayed pluripotent cell morphology (Fig. 1B),
expressed pluripotency related genes (Fig. 1C) and were positive for a
set of pluripotent markers OCT3/4, NANOG, TRA-1-60 and TRA-1-81
as well as alkaline phosphatase (Fig. 1D). The cells had the capability
to differentiate into the derivatives from all the three germ layers both
in vitro (Fig. 1E) and in vivo (Fig. 1F). In addition, this line maintained
the normal karyotype 46, XX during long-term culture (Fig. 1G).2. Materials and methods
2.1. hESC line derivation and cell culture
The ethical committee of Reproductive and Genetic Hospital of
CITIC-Xiangya approved the study. A blastocyst with disease-causing
mutation was donated by a Marfan syndrome patient with informed
consent. Themethodology used for hESC line derivationwas performed
as previously described (Lin et al., 2009). The inner cell mass was
mechanically isolated and plated on mouse embryonic ﬁbroblast
(MEF) feeders. The cells were cultured in ES medium containing
DMEM/F12 supplemented with 15% knockout serum replacement,
2 mM nonessential amino acids, 2 mM L-glutamine, 0.1 mM β-
mercaptoethanol and 4 ng/mL of basic Fibroblast Growth Factor
(bFGF) (all from Invitrogen). Once the embryo outgrowth was
observed, it was transmitted onto fresh feeders and obtained the(http://creativecommons.org/licenses/by-nc-nd/4.0/).
ig. 1. Characterization of chHES-419 cells. (A) A heterozygousmutation, c.3536delA, of FBN1was identiﬁed in chHES-419 cells; (B) cells showed typical round shape colonies on theMEF
eder layer; (C) pluripotent genes expressed in chHES-419 cells, NANOG, OCT3/4, SOX2, TERF1, THY1 and KLF4 were detected by RT-PCR; (D) undifferentiated colonies were positive for
e pluripotency markers of NANOG, OCT4, TRA-1-60, TRA-1-81 and AKP. Nuclei staining with DAPI was in the lower right corner. Scale bar = 100 μm; (E) derivatives from embryoid
odies of chHES-419 cells could differentiate into ectoderm (TUJ1), mesoderm (SMA) and endoderm (AFP) in vitro. Scale bar = 50 μm; (F) histological sections of teratomas formed by
e chHES-419 hESC line contain tissues derived from three germ layers. Scale bar = 50 μm; (G) chHES-419 has a normal karyotype 46, XX.
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Table 1
List of primers used in RT-PCR.
Genes Primer sequence Temp. (°C)
Product size
(bp)
NANOG
5′-TGAACCTCAGCTACAAACAG-3′
56 154
5′-TGGTGGTAGGAAGAGTAAAG-3′
OCT3/4
5′-AGCGAACCAGTATCGAGAAC-3′
56 142
5′-TTACAGAACCACACTCGGAC-3′
SOX2
5′-AGCTACAGCATGATGCAGGA-3′
56 126
5′-GGTCATGGAGTTGTACTGCA-3′
TERF1
5′-GCAACAGCGCAGAGGCTATTATT-3′
58 159
5′-AGGGCTGATTCCAAGGGTGTAA-3′
THY1
5′-AGAATACCAGCAGTTCACCCATCC-3′
58 273
5′-CCTCACACTTGACCAGTTTGTCTCTG-3′
KLF4
5′-GCCGCTCCATTACCAAGAGC-3′
57 167
5′-GGTGTGCCTTGAGATGGGAA-3′
β-ACTIN
5′-TCCCTGGAGAAGAGCTACGA-3′
58 194
5′-AGCACTGTGTTGGCGTACAG-3′
642 Q. Yang et al. / Stem Cell Research 15 (2015) 640–642hESC-colonymorphology during prolonged culture. hESC colonieswere
mechanically passaged every 7 days.
2.2. Genetic diagnosis.
Genomic DNAof the cells was extracted using QIAmp®DNAmini kit
(QIAGEN). PCR was conducted using 50 μL PCR ampliﬁcation reaction
mixture which contained 1.5 μL of 100 ng genomic DNA, 1 μL of
1.0 μM of each primer (the forward primer: 5′-GCCAAAGTTGGAAGCT
TATG-3′ and the reverse primer: 5′-TAACATAACATAACATAAAATA
AAG-3′) and 25 μL of 2 × GreenMaster Mix (Promega). Cycling condi-
tions were as follows: 95 °C for 1.5 min followed by 35 cycles of ampli-
ﬁcation (95 °C denaturation for 40 s, 56 °C annealing for 40 s, 72 °C
elongation for 40 s) and a ﬁnal extension at 72 °C for 5 min. The PCR
products were determined by Sanger sequencing using a BigDye Termi-
nator cycle sequencing kit v3.1 and an ABI 3130XL Genetic Analyzer
(Applied Biosystems).
2.3. RT-PCR
Total RNA was extracted with TRIzol (Invitrogen) and complemen-
tary DNA (cDNA) was synthesized via using Transcriptor First Strand
cDNA Synthesis Kit (Roche). The RT-PCR reaction was carried out as
follows: 95 °C for 2 min; 35 cycles of ampliﬁcation (95 °C for 30 s, 54–
64 °C for 30 s and 72 °C for 30 s) and a ﬁnal extension at 72 °C for
5 min. PCR products were separated by electrophoresis on a 1.5%
agarose gel, and images were taken on a UV transluminator. The
primers were listed in Table 1.
2.4. Immunocytochemistry and alkaline phosphatase staining
chHES-419 cells were ﬁxed with 4% paraformaldehyde (PFA), then
blockedwith 10% donkey serumand incubatedwith primary antibodies
overnight at 4 °C. For intracellular antigen, cells were permeabilized in
0.2% Triton-X 100 before blocking. The following primary antibodies
were used: mouse anti-OCT4 (1:200, Santa Cruz Biotechnology), rabbitanti-NANOG (1:100, Abcam), mouse anti-TRA-1-60 (1:50, Millipore),
mouse anti-TRA-1-81 (1:50, Millipore), mouse anti-β-tubulin (1:800,
Sigma), mouse anti-AFP (1:500, Sigma), and mouse anti-SMA (1:100,
Millipore). After rinsing to remove unbound antibodies, Localization of
antigens was visualized by using Alexa Fluor® 488 donkey anti-mouse
lgG (1:1000, Life Technologies) or Alexa Fluor® 488 donkey anti-
rabbit lgG (1:1000, Life Technologies). Nuclei were counterstained
with DAPI (1:1000, Sigma). In addition, alkaline phosphatase activity
was detected with BCIP/NBT Kit (Invitrogen). Images were acquired in
an epiﬂuorescence microscopy (Nikon Eclipse TE2000-U).
2.5. In vitro and in vivo differentiation assay
For in vitro differentiation assay, hESCs were detached to grow as
aggregates in suspension for 7 days in ES medium without bFGF, then
transmitted onto Matrigel (BD) coated 4-well plates for another 14-
day culture. The derivatives of embryoid bodies were processed for
immunocytochemistry analysis.
For in vivodifferentiation assay, 1 × 106 cells were injected intomus-
cle of right hind limb of SCID mouse. After 10 weeks, teratoma was
harvested and ﬁxed with 4% paraformaldehyde. To identify the deriva-
tives from three germ layers, hematoxylin and eosin (H&E) staining
(Fig. 1G) was carried out for the histological analysis.
2.6. Karyotyping analysis
chHES-419 cells were cultured in mTeSR™1(STEMCELL) for 3–
5 days, then treatedwith 0.1 μg/mL of KaryoMAX® Colcemid™ solution
(Life Technologies) for 3 h and dissociated with Accutase (Millipore)
into single cells for standard G-banding karyotype analysis.
2.6.1. Veriﬁcation and Authentication.
Karyotyping and sequencing analysis were performed at Reproduc-
tive & Genetic Hospital of CITIC-Xiangya. Twenty metaphase cells were
observed and all had a normal karyotype of 46, XX. After locus speciﬁc
PCR, Sanger sequencing analysis conﬁrmed a heterozygous deletion
mutation, c.3536delA, of FBN1 in chHES-419 cells that is consistent
with that of the proband.
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